发明名称 Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug
摘要 Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
申请公布号 US9456985(B2) 申请公布日期 2016.10.04
申请号 US201514697891 申请日期 2015.04.28
申请人 UPSHER-SMITH LABORATORIES, INC. 发明人 Wertz Christian F.;Jensen James S.;O'Neill Victoria Ann;Mahoney Sean B.;Berge Stephen M.
分类号 A61K9/20;A61K31/44;A61K31/19;A61K31/13;A61K31/135;A61K31/46;A61K31/485;A61K31/138;A61K31/192 主分类号 A61K9/20
代理机构 Mueting, Raasch & Gebhardt, P.A. 代理人 Mueting, Raasch & Gebhardt, P.A.
主权项 1. A sustained-release oral pharmaceutical composition comprising within a single dosage form: a hydrophilic matrix comprising a cellulose ether selected from the group consisting of a hydroxyalkyl cellulose, a carboxyalkyl cellulose, and a combination thereof; a therapeutically effective amount of a non-opioid amine-containing compound; and a salt of a non-steroidal anti-inflammatory drug (NSAID); wherein the non-opioid amine-containing compound and the salt of an NSAID are within the hydrophilic matrix; and wherein the composition exhibits a release profile with respect to the non-opioid amine-containing compound, wherein the release profile comprises a substantial portion that is representative of zero-order release kinetics under in vitro conditions as a result of dissolution of the hydrophilic matrix.
地址 Maple Grove MN US